This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, T. F. Articles by Frankel, A. E. Search for Related Content PubMed PubMed Citation Articles by Liu, T. F. Articles by Frankel, A. E.

A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells¹

Department of Cancer Biology and Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157

The cytotoxicity of a diphtheria toxin-human epidermal growth factor fusion protein (DAB₃₈₉EGF) was tested against 14 human glioma cell lines. After cells were cultured for 48 h with various concentrations of DAB₃₈₉EGF, the percentage reduction in thymidine incorporation was determined. For 13 of 14 cell lines, potent cytotoxicity was observed, with IC₅₀s of 0.4–50 pM. The epidermal growth factor receptor (EGFR) density of these cell lines was determined by immunofluorescence microscopy, flow cytometry, and radioligand binding. These assays correlated well with each other and demonstrated EGFR levels of 15,000–230,000/cell for 13 of 14 cell lines. The cell line U138MG, which lacked EGFR, was the only cell line insensitive to DAB₃₈₉EGF. Linear regression analysis showed a good correlation between EGFR density and DAB₃₈₉EGF sensitivity (P < 0.001) and between results of flow cytometry and radiolabeled binding assays of EGFR density (P = 0.01). DAB₃₈₉EGF may have potential for intracranial therapy of EGFR-positive glioblastomas.

This article has been cited by other articles:

				T. F. Liu, J. Cai, D. M. Gibo, and W. Debinski Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin Clin. Cancer Res., January 1, 2009; 15(1): 160 - 168. [Abstract] [Full Text] [PDF]

				T. F. Liu, P. D. Hall, K. A. Cohen, M. C. Willingham, J. Cai, A. Thorburn, and A. E. Frankel Interstitial Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Therapy Produces Regressions of Subcutaneous Human Glioblastoma Multiforme Tumors in Athymic Nude Mice Clin. Cancer Res., January 1, 2005; 11(1): 329 - 334. [Abstract] [Full Text] [PDF]

				T. F. Liu, S. B. Tatter, M. C. Willingham, M. Yang, J. J. Hu, and A. E. Frankel Growth Factor Receptor Expression Varies among High-Grade Gliomas and Normal Brain: Epidermal Growth Factor Receptor Has Excellent Properties for Interstitial Fusion Protein Therapy Mol. Cancer Ther., August 1, 2003; 2(8): 783 - 787. [Abstract] [Full Text] [PDF]